Lateral Flow Assays (LFA) Market Size & Share, Growth Trends 2035

Global Market Size, Forecast, and Trend Highlights Over 2023 Ã¢â‚¬â€œ 2035

Lateral Flow Assays Market size is projected to cross USD 180 billion by the end of 2035, growing at a CAGR of 7% during the forecast period i.e., 2023 – 2035. In the year 2022, the industry size of lateral flow assays was USD 11 billion. The growth of the market is mainly due to the increasing prevalence of infectious diseases. According to the World Health Organization (WHO), infectious diseases are the leading cause of death worldwide, accounting for about 25% of all deaths worldwide.

Increasing demand for diagnostic test products that use lateral flow technology for the detection of diseases, is further predicted to drive the lateral flow assays market. In 2020, an estimated 38 million people were living with HIV/AIDS worldwide, with 1.5 million new infections and 690,000 deaths. Tuberculosis (TB) remains one of the top 13th causes of death globally with about 10.6 million new cases and 1.6 million deaths in 2021.

Get more information on this report: Request Free Sample PDF

Lateral Flow Assays Market: Key Insights

Base Year	2022
Forecast Year	2023 – 2035
CAGR	~7%
Base Year Market Size (2022)	~USD 11 billion
Forecast Year Market Size (2035)	~USD 180 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Lateral Flow Assays Sector: Growth Drivers and Challenges

Growth Drivers

Increasing Research Costs – The growth of the global lateral flow assays market is driven by increased investment in research and development activities. This helps to find more viable solutions for biosafety cabinets. Research reports show that global R&D spending has grown from around USD 680 billion to over USD 2.5 trillion in 2020.
Growing Demand for Point-of-the-Care Testing – Point-of-the-care diagnostics devices have become increasingly important in recent years due to their ability to provide fast and accurate results in a variety of environments. Lateral flow assays are well suited to POCTs due to their simplicity, portability, and ease of use.
Growing Demand for Food Safety Testing - The demand for food safety testing is increasing globally, due to factors such as the increasing incidence of foodborne illnesses, and safety regulations. Food changes and consumer awareness is increasing about the safety and quality of the food they eat. Side flow testing is widely used for food safety testing due to its ease of use, fast turnaround time, and ability to detect a wide range of contaminants such as pathogens, toxins, and allergens.

Challenges

Lack of Sensitivity and Specificity – Lateral flow assays are known to have limitations in terms of sensitivity and specificity compared to other diagnostic methods, such as PCR or ELISA. This can lead to false-positive or false-negative results, which can be a significant challenge in various applications.
Competition from Substitute Technologies
Regulatory Limitations Associated

Lateral Flow Assays Segmentation

End Users (Hospitals, Diagnostic Laboratories, Pharmaceutical Companies)

The diagnostic laboratory segment is estimated to hold the largest share of the lateral flow assays market during the time period between 2023 - 2035. The growth of the segment is driven by increased demand for flow analysis testing. Moreover, for any viral spread of infections, lateral flow tests are used by various institutions and governments to confirm symptomatic and asymptomatic infections.

Product (Kits & Reagents, Lateral Flow Readers)

Lateral flow assays (LFA) market from the kits and reagents segment is set to occupy a noteworthy gain of 60% by the end of 2035. The growth of this segment is driven by the growing demand for rapid anti-care tests. These products are widely used in different environments, such as clinics, hospitals, and home testing, due to their simplicity, ease of use, and anti-fast turnaround times. The growth of new innovative anti-horizontal scanning technologies, such as smartphone-based anti-flow digital scanning, is also driving demand for kits and reagents.

Our in-depth analysis of the global lateral flow assays (LFA) market includes the following segments:

Product	Kits & Reagents Lateral Flow Readers
End Users	Hospitals Diagnostic Laboratories Pharmaceutical Companies

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Lateral Flow Assays Landscape Ã¢â‚¬â€œ Regional Synopsis

APAC Market Forecasts

The Asia-Pacific lateral flow analysis market is predicted to hold the largest share of 34% during the assessment period. The Asia-Pacific region has a high burden of infectious diseases, which is driving the need for lateral flow testing for rapid and accurate diagnosis. Several countries in the Asia-Pacific region such as China and India are investing heavily in health infrastructure.

North American Market Statistics

The North America lateral flow analysis market is assumed to hold a notable share of 26 % during the forecast period. North America is at the heart of technological advancements, driving the development of new and innovative transverse flow analysis technologies, and is anticipated to drive the growth of the market in the region.

Get more information on this report: Request Free Sample PDF

Companies Dominating the Lateral Flow Assays (LFA) Market

Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Becton, Dickinson, and Company
Bio-Rad Laboratories, Inc.
Danaher Corporation
F.Hoffmann-La Roche AG
QIAGEN N.V.
Siemens Healthineers AG
Thermo Fisher Scientific, Inc.
Merck kGaA
PerkinElmer Inc.

In The News

Abbott Laboratories announced the launch of a new lateral flow antigen test called the BinaxNOW COVID-19 Ag Card home test. This test is intended for non-prescription, and over-the-counter use, and provides results in 15 minutes. It is the first COVID-19 test authorized for non-prescription use by the US Reel and Drug Administration (FDA).
Becton, Dickinson, and Company: SD announced the acquisition of a lateral now and clinical diagnostics company, Infiammatix. Inflammatix's technology enables rapid diagnosis and triage of patients with suspected infectious or inflammatory conditions. The acquisition is expected to enhance BD's diagnostic capabilities and expand its presence in the infectious disease market.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the lateral flow assays market?

Ans: The growing prevalence of infectious diseases and spiking healthcare spending are some of the major factors anticipated to drive the growth of the lateral flow assays market.

2) What would be the CAGR of the lateral flow assays market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023 Ã¢â‚¬â€œ 2035.

3) Who are the major players dominating the lateral flow assays market?

Ans: The major players in the market are Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffmann-La Roche AG, QIAGEN N.V., Seimens Healthineers AG, Thermo Fisher Scientific, Inc., Merck kGaA, PerkinElmer Inc., and others.

4) Which segment captures the largest market size in products in the lateral flow assays market?

Ans: The kits & reagent segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

5) Which region will provide more business opportunities for the growth of the lateral flow assays market in the future?

Ans: The market in Asia Pacific is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

Lateral Flow Assays (LFA) Market Size & Share, by Product (Kits & Reagents, Lateral Flow Readers); End-user (Hospitals, Diagnostic Laboratories, Pharmaceutical Companies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035